Radiofrequency-based ablation for atrial fibrillation appears more effective than previously shown in clinical trials. Using real-world data, a new study found that the procedure eliminated atrial ...
The patients were suffering from persistent ventricular premature contractions (VPCs), presenting as ventricular bigeminy — a condition in which nearly every alternate heartbeat is abnormal.
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
Please provide your email address to receive an email when new articles are posted on . Several Biosense Webster AF ablation products received FDA approval for use without fluoroscopy. Use of ...
London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...
Study incorporated data from over 25,000 patients across 30 sites and compared proactive esophageal cooling to luminal temperature monitoring during RF ablation of the left atrium. CHICAGO--(BUSINESS ...
MedPage Today on MSN
Pulsed field ablation safety issues: Will newer devices clear the stumbling block?
Pulsed field ablation (PFA) has been embraced as a catheter ablation modality with potential to be safer for atrial ...
Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...
CHICAGO--(BUSINESS WIRE)--Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results